FDA Approves KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in ... - MarketWatch (press release)

TopNews United Kingdom (blog)

FDA Approves KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in ... MarketWatch (press release) During the next three months of therapy (months 4 through 6), gout flares occurred in 41% of patients treated with KRYSTEXXA every 2 weeks and in 67% of ... Savient: FDA clears drug for chronic goutBusinessWeek FDA Clears Savient's Gout Therapy for Patients Refractive to Xanthine Oxidase ...Genetic Engineering News First Biologic for Gout, Krystexxa, ApprovedArthritis Today Triangle Business Journal -Medscape -MedPage Today all 199 news articles »

Q Nutrition: Arthritis is not always to blame for aches and pains - San Diego Gay & Lesbian News

San Diego Gay & Lesbian News

Q Nutrition: Arthritis is not always to blame for aches and pains San Diego Gay & Lesbian News These are some things to consider when arthritis symptoms occur – Nightshade foods, Artificial sweeteners, MSG, stevia, Prescription drugs, Gout, Hormones, ...

Biochemistry is applicable to all medical fields - Iran Book News Agency

Iran Book News Agency

Biochemistry is applicable to all medical fields Iran Book News Agency 16 various diseases such as gout and pestilence could be treated by biochemistry. This author and physician also emphasized upon the role of biochemistry in ...

Health Buzz: FDA OK's Gout Drug Krystexxa - U.S. News & World Report

Health Buzz: FDA OK's Gout Drug Krystexxa U.S. News & World Report About 20 percent of healthy Americans are Type D's, as are up to half of people being treated for heart problems, says study author Johan Denollet, ... and more »